New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
12:51 EDTINSMInsmed price target raised to $30 from $25 at H.C. Wainwright
H.C. Wainwright raised its price target for Insmed shares to $30 following the company's Phase II data for Arikayce and keeps a Buy rating on the stock. The firm believes uncertainty over the drug's clinical meaningfulness has been removed with the data.
News For INSM From The Last 14 Days
Check below for free stories on INSM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 12, 2014
19:27 EDTINSMInsmed 8.9M share Secondary priced at $11.25
Leerink acted as sole book running manager for the offering.
August 11, 2014
17:26 EDTINSMPoint72 Asset reports 5.4% passive stake in Insmed
Subscribe for More Information
16:40 EDTINSMInsmed files to sell $80M of common stock
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use